Related Experiment Video

Updated: Dec 6, 2025

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.5K

In Silico Cloning of Target Type 2 Diabetes Population for Treatments Development and Decision Support.

Roberto Visentin, Michele Schiavon, Chiara Dalla Man

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |October 6, 2020
    PubMed

    Insights

    A new method tunes type 2 diabetes (T2D) simulators for diverse patient groups, including insulin-naïve individuals. This advances in silico trials for drug development and treatment optimization in T2D.

    Area of Science:

    • Computational biology
    • Pharmacology
    • Endocrinology

    Background:

    • Type 2 diabetes (T2D) treatments vary by disease stage.
    • In silico trials accelerate drug development and optimize treatments.
    • Existing T2D simulators are limited to early-stage T2D data.

    Purpose of the Study:

    • To develop a method for tuning T2D simulators to specific patient populations.
    • To enable in silico testing of treatments in diverse T2D subpopulations without extensive clinical studies.

    Main Methods:

    • Proposed a method to adapt a T2D simulator (T2DS) to new target populations.
    • Utilized a case study to extend the T2DS for insulin-naïve T2D subjects.
    • Demonstrated tuning without complex clinical studies.

    Main Results:

    • Successfully adapted the T2DS to simulate insulin-naïve T2D patient behavior.
    • Validated the tuning methodology for broader T2D population applicability.
    • Showcased the potential for in silico testing in new T2D cohorts.

    Conclusions:

    • The proposed tuning method expands the utility of T2D simulators.
    • This approach facilitates in silico testing for various T2D stages and patient types.
    • Enables efficient pre-clinical evaluation of T2D therapies.

    More Related Videos

    An In Ovo Model for Testing Insulin-mimetic Compounds06:09

    An In Ovo Model for Testing Insulin-mimetic Compounds

    Published on: April 23, 2018

    11.0K
    Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets10:09

    Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

    Published on: May 11, 2015

    9.9K

    Related Concept Videos

    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    4.1K
    EPS and iPS Cells in Disease Research01:21

    EPS and iPS Cells in Disease Research

    Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
    3.2K
    Diabetes Mellitus: Overview and Type I Subtype01:22

    Diabetes Mellitus: Overview and Type I Subtype

    Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
    Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
    4.6K
    Carbohydrate Metabolism01:36

    Carbohydrate Metabolism

    Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
    Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
    13.2K
    Diabetes: Management and Pharmacotherapy01:15

    Diabetes: Management and Pharmacotherapy

    The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
    Insulin remains the cornerstone of treatment for most patients with type 1 and many...
    760